PyInvesting

Market research

603351.SHG Nanjing Well Pharmaceutical Group Co.,Ltd

SHG CNY Healthcare

Latest close

26.64 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
4B
P/E ratio
23.4
Analyst target
Not available
Dividend yield
2.3%
Beta
0.32

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Nanjing Well Pharmaceutical Group Co.,Ltd is currently in a long term downtrend where the price is trading 10.9% below its 200 day moving average.

From a valuation standpoint, the stock is 58.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.

Nanjing Well Pharmaceutical Group Co.,Ltd's total revenue sank by 19.6% to $179M since the same quarter in the previous year.

Its net income has dropped by 46.4% to $18M since the same quarter in the previous year.

Finally, its free cash flow fell by 492.2% to $-73M since the same quarter in the previous year.

Based on the above factors, Nanjing Well Pharmaceutical Group Co.,Ltd gets an overall score of 1/5.